drugset / Trial / NCT01388946

Analgesia in Laparoscopic Cholecystectomy

NCT01388946 ↗

Completed 110 enrolled University of Athens
RandomizedParallel-groupTriple-blindTreatment

Summary

The investigators hypothesis is that perioperative infusion of 0.75 ropivacaine in patients undergoing laparoscopic cholecystectomy may modify the intensity of postoperative pain or the analgesic consumption during the first 24 hours.

Timeline

Start
2010-05
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ropivacaine Other / unclassified 7.5 mg/ml Subcutaneous